AvePoint Insider Files Rule 144 to Sell 35,000 Shares on NASDAQ

Rhea-AI Filing Summary

AvePoint, Inc. (AVPT) filing reports a proposed sale of 35,000 common shares through Rockefeller Financial with an aggregate market value of $543,633.74, with an approximate sale date of 09/23/2025. The shares were originally received as a restricted stock grant on 07/07/2022 and were granted as compensation. The issuer has 211,926,808 shares outstanding. The filer previously sold three blocks of 35,000 shares on 06/23/2025, 07/23/2025 and 08/25/2025, with gross proceeds shown for each transaction. The notice includes the standard representation regarding absence of undisclosed material information.

Positive

• Full Rule 144 disclosure provided including acquisition date, nature of acquisition, broker and planned sale date
• Prior three-month sale history is disclosed with dates and gross proceeds, increasing transparency
• Securities were acquired as compensation and the filing states the filer affirms no undisclosed material information

Negative

• Concentrated insider selling shown by three recent 35,000-share sales in the past three months, which may attract investor attention

Insights

Securities Analyst

TL;DR Routine Rule 144 notice for previously granted restricted shares; transactions appear procedural, not material to cap table.

The filing documents a planned disposition of 35,000 common shares by an insider under Rule 144, acquired via a restricted stock grant on 07/07/2022 and listed for sale through Rockefeller Financial. Given the issuer's 211,926,808 shares outstanding, the block represents a small fraction of equity, suggesting limited direct dilution or market impact. The filing also discloses three recent sales of identical block sizes with reported gross proceeds, improving transparency around insider liquidity activities.

Corporate Governance Expert

TL;DR Disclosure meets Rule 144 requirements; repeated recent sales merit monitoring but are procedurally compliant.

The notice contains required acquisition details, sale plans, broker identification, and prior three-month sale history, aligning with disclosure standards. The filer affirms no undisclosed material information. Multiple near-term sales by the same person are disclosed, which is compliant but may be of interest to stakeholders monitoring insider selling patterns. No governance red flags or regulatory exceptions are evident from the data provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Financial 200 South 10th Street Suite 950 Richmond VA 23219	35000	543633.74	211926808	09/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/07/2022	Restricted Stock Grant	AVPT			35000	07/07/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brown Brian Michael 4101 WELBY DR MIDLOTHIAN VA 23113	Common	08/25/2025	35000	540484.90
Brown Brian Michael 4101 WELBY DR MIDLOTHIAN VA 23113	Common	06/23/2025	35000	638057.00
Brown Brian Michael 4101 WELBY DR, MIDLOTHIAN VA 23113	Common	07/23/2025	35000	654941.73

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by AVPT report?

The filing reports a proposed sale of 35,000 common shares with aggregate market value $543,633.74 and an approximate sale date of 09/23/2025.

How and when were the shares being sold on AVPT acquired?

The shares were acquired as a restricted stock grant on 07/07/2022 and the stated nature of payment was compensation.

Who is the broker handling the proposed sale of AVPT shares?

The broker listed is Rockefeller Financial located at 200 South 10th Street, Suite 950, Richmond, VA.

Has the filer sold AVPT shares recently?

Yes. The filing discloses three sales of 35,000 shares each on 06/23/2025, 07/23/2025, and 08/25/2025 with gross proceeds reported for each transaction.

How large is the sale relative to AVPT's outstanding shares?

The proposed 35,000-share sale is set against 211,926,808 shares outstanding, representing a very small fraction of total equity.